One could speculate that the activity of ADAMTS13 at the endothelial surface would be the most important in patients, since it is the site of the most active VWF multimers, especially, under conditions that trigger USS episodes. The gene discussed is VWF; the disease is congenital thrombotic thrombocytopenic purpura.